Counterfeit cholesterol drugs worth Rs 3 lakh seized in raids at Koti

Officials from the Drugs Control Administration (DCA) carried out raids on multiple pharmaceutical dealers in Koti, Hyderabad and uncovered counterfeit stocks of the cholesterol-lowering medications Rosuvas F 20 and Rosuvas F 10.

These drugs are prescribed to lower cholesterol and triglyceride levels and prevent heart-related ailments. The spurious drugs were being circulated in the open market under the guise of legitimate products manufactured by Sun Pharmaceutical Industries Limited.

During the inspections on Thursday, DCA’s special enforcement team raided two outlets, Ganga Pharma Distributors and Sri Nandini Pharma, and seized fake batches of the medicine, both falsely labelled as being manufactured in December 2024 and set to expire in May 2027. The counterfeit packaging claimed Sun Pharma’s Sikkim unit as the manufacturing site, said a release. The estimated value of the seized counterfeit medicines is ₹3 lakh.

Upon verification, Sun Pharmaceutical Industries Limited confirmed to the authorities that the seized stocks were not genuine and had not been produced by their company. Officials stated that a detailed investigation is underway to trace the entire supply chain of the counterfeit products and that legal action will be initiated against all those found responsible.

Source: The Hindu

Related Posts

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

‘Where the product in question is a life-saving drug, the Court has to err in favour of public interest’, said the bench The Delhi High Court on Monday cleared the…

DoP may exempt 11 more drugs from public procurement rules

New Delhi: The Department of Pharmaceuticals (DoP) has proposed to add 11 more drugs including insulin and monoclonal antibodies to the list of 84 drug formulations it has mentioned in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

DoP may exempt 11 more drugs from public procurement rules

DoP may exempt 11 more drugs from public procurement rules

DoP calls for proposals to set up common facilities for medical device clusters

DoP calls for proposals to set up common facilities for medical device clusters

TN Information Commission raps petitioner for abusing RTI Act with excessive requests

TN Information Commission raps petitioner for abusing RTI Act with excessive requests

Granules India gets USFDA tentative nod for generic ADHD treatment tablets

Granules India gets USFDA tentative nod for generic ADHD treatment tablets

Polymatech begins domestic manufacturing of vein finder devices

Polymatech begins domestic manufacturing of vein finder devices